Supplements for article: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study

Published: 20 September 2024| Version 1 | DOI: 10.17632/9xvwbfz598.1
Contributors:
Amy Paller, Jonathan Silverberg, Eric Simpson, Michael Cork, Peter Arkwright, Zhen Chen, Ashish Bansal, Randy Prescilla, Zhixiao Wang, Ainara Marco

Description

Supplements for article with title: The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study Journal: Journal of the American Academy of Dermatology

Files

Categories

Atopic Dermatitis, Quality of Life, Quality of Sleep, Patient-Reported Outcome

Funding

Regeneron Pharmaceuticals

Sanofi

Licence